By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
PulseReporterPulseReporter
  • Home
  • Entertainment
  • Lifestyle
  • Money
  • Tech
  • Travel
  • Investigations
Reading: Biogen (BIIB) earnings Q3 2024
Share
Notification Show More
Font ResizerAa
PulseReporterPulseReporter
Font ResizerAa
  • Home
  • Entertainment
  • Lifestyle
  • Money
  • Tech
  • Travel
  • Investigations
Have an existing account? Sign In
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
PulseReporter > Blog > Money > Biogen (BIIB) earnings Q3 2024
Money

Biogen (BIIB) earnings Q3 2024

Last updated: October 30, 2024 12:50 pm
8 months ago
Share
Biogen (BIIB) earnings Q3 2024
SHARE


Contents
Extra CNBC well being protectionDon’t miss these insights from CNBC PRO

A take a look at tube is seen in entrance of displayed Biogen emblem on this illustration taken on, December 1, 2021.

Dado Ruvic | Reuters

Biogen on Wednesday reported third-quarter income and adjusted earnings that topped expectations whereas elevating its full-year revenue steerage, as gross sales of its breakthrough Alzheimer’s drug, Leqembi, and different new merchandise achieve traction. 

Biogen now expects full-year adjusted earnings to come back in between $16.10 and $16.60 per share, up from a earlier forecast of $15.75 to $16.25 per share. The biotech firm nonetheless anticipates 2024 gross sales to say no by a low-single-digit proportion. 

Leqembi, which Biogen shares with the Japanese drugmaker Eisai, grew to become the second drug confirmed to gradual the development of Alzheimer’s to win approval within the U.S. final summer season. The remedy’s launch has been gradual attributable to bottlenecks associated to diagnostic take a look at necessities, common mind scans and discovering neurologists, amongst different points. 

Extra CNBC well being protection

Nonetheless, uptake of Leqembi has been rising over the previous couple of quarters. The therapy introduced in $67 million in gross sales for the third quarter, together with $39 million from the U.S. 

Wall Avenue analysts had anticipated world gross sales of $50 million for Leqembi, in response to estimates compiled by StreetAccount. The drug posted simply $10 million in gross sales final yr following its launch. 

It’s unclear what number of sufferers are presently taking the drug. Leqembi, together with Biogen’s new uncommon illness and despair therapies, helped offset a year-over-year decline in income for the corporate’s a number of sclerosis merchandise. 

This is what Biogen reported for the third quarter in contrast with what Wall Avenue was anticipating, primarily based on a survey of analysts by LSEG: 

  • Earnings per share: $4.08 adjusted vs. $3.79 anticipated
  • Income: $2.47 billion vs. $2.43 billion anticipated

Biogen booked gross sales of $2.47 billion for the quarter, which is down round 3% from the year-earlier interval. 

The drugmaker posted web earnings of $388.5 million, or $2.66 per share, for the interval ended Sept. 30. That compares with a web lack of $68.1 million, or 47 cents per share, for a similar interval a yr in the past. 

Adjusting for one-time objects, together with sure restructuring costs and prices related to intangible belongings, the corporate reported earnings of $4.08 per share.

Don’t miss these insights from CNBC PRO

You Might Also Like

Jamie Dimon needs to ban the ‘disrespectful’ behavior of checking emails in conferences

Mark Zuckerberg wore one of many rarest watches on the planet, value $900,000, whereas asserting the top of fact-checking at Meta

Disney and Caterpillar slated to report this week

Extra main companies are dropping Human Rights Marketing campaign’s LGBTQ+ rights report card

Digital advertising and marketing was about clicks, however the rise of ChatGPT means it’s ‘now all about profitable the mentions’

Share This Article
Facebook Twitter Email Print
Previous Article Liam Payne’s Posthumous Music Delayed Indefinitely Liam Payne’s Posthumous Music Delayed Indefinitely
Next Article Issues to not do when you’ve got cruise line loyalty standing Issues to not do when you’ve got cruise line loyalty standing
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!

More News

Prime Day is Lastly Over However These 143 Offers Are Nonetheless Obtainable
Prime Day is Lastly Over However These 143 Offers Are Nonetheless Obtainable
29 minutes ago
Gen Z males are nonetheless obsessive about Pokémon playing cards—utilizing ‘boy math’ to argue that they’re going to beat Nvidia inventory and the S&P 500. However there is a catch
Gen Z males are nonetheless obsessive about Pokémon playing cards—utilizing ‘boy math’ to argue that they’re going to beat Nvidia inventory and the S&P 500. However there is a catch
39 minutes ago
Disney Characters Made With A Single Line
Disney Characters Made With A Single Line
52 minutes ago
Get an all-in-one AI instrument, for all times for simply £23
Get an all-in-one AI instrument, for all times for simply £23
1 hour ago
Are airline bank cards price it anymore?
Are airline bank cards price it anymore?
2 hours ago

About Us

about us

PulseReporter connects with and influences 20 million readers globally, establishing us as the leading destination for cutting-edge insights in entertainment, lifestyle, money, tech, travel, and investigative journalism.

Categories

  • Entertainment
  • Investigations
  • Lifestyle
  • Money
  • Tech
  • Travel

Trending

  • Prime Day is Lastly Over However These 143 Offers Are Nonetheless Obtainable
  • Gen Z males are nonetheless obsessive about Pokémon playing cards—utilizing ‘boy math’ to argue that they’re going to beat Nvidia inventory and the S&P 500. However there is a catch
  • Disney Characters Made With A Single Line

Quick Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service
  • Disclaimer
2024 © Pulse Reporter. All Rights Reserved.
Welcome Back!

Sign in to your account